Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 26
2003 14
2004 16
2005 15
2006 25
2007 24
2008 17
2009 14
2010 14
2011 19
2012 17
2013 28
2014 12
2015 21
2016 19
2017 11
2018 5
2019 12
2020 8
2021 9
2022 10
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

314 results

Results by year

Filters applied: . Clear all
Page 1
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension.
Desai AS, Webb DJ, Taubel J, Casey S, Cheng Y, Robbie GJ, Foster D, Huang SA, Rhyee S, Sweetser MT, Bakris GL. Desai AS, et al. Among authors: webb dj. N Engl J Med. 2023 Jul 20;389(3):228-238. doi: 10.1056/NEJMoa2208391. N Engl J Med. 2023. PMID: 37467498 Clinical Trial.
Endothelin.
Davenport AP, Hyndman KA, Dhaun N, Southan C, Kohan DE, Pollock JS, Pollock DM, Webb DJ, Maguire JJ. Davenport AP, et al. Among authors: webb dj. Pharmacol Rev. 2016 Apr;68(2):357-418. doi: 10.1124/pr.115.011833. Pharmacol Rev. 2016. PMID: 26956245 Free PMC article. Review.
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial.
Mackenzie IS, Rogers A, Poulter NR, Williams B, Brown MJ, Webb DJ, Ford I, Rorie DA, Guthrie G, Grieve JWK, Pigazzani F, Rothwell PM, Young R, McConnachie A, Struthers AD, Lang CC, MacDonald TM; TIME Study Group. Mackenzie IS, et al. Among authors: webb dj. Lancet. 2022 Oct 22;400(10361):1417-1425. doi: 10.1016/S0140-6736(22)01786-X. Epub 2022 Oct 11. Lancet. 2022. PMID: 36240838 Free PMC article. Clinical Trial.
Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor-Sparing Strategies for Counteracting Blood Pressure Lowering by Angiotensinogen-Targeting Small Interfering RNA.
Ranasinghe P, Addison ML, Webb DJ. Ranasinghe P, et al. Among authors: webb dj. J Am Heart Assoc. 2022 Oct 18;11(20):e027694. doi: 10.1161/JAHA.122.027694. Epub 2022 Oct 10. J Am Heart Assoc. 2022. PMID: 36216481 Free PMC article. No abstract available.
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.
Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, Ford I, Cruickshank JK, Caulfield MJ, Salsbury J, Mackenzie I, Padmanabhan S, Brown MJ; British Hypertension Society's PATHWAY Studies Group. Williams B, et al. Among authors: webb dj. Lancet. 2015 Nov 21;386(10008):2059-2068. doi: 10.1016/S0140-6736(15)00257-3. Epub 2015 Sep 20. Lancet. 2015. PMID: 26414968 Free PMC article. Clinical Trial.
Endothelium-derived endothelin-1.
Thorin E, Webb DJ. Thorin E, et al. Among authors: webb dj. Pflugers Arch. 2010 May;459(6):951-8. doi: 10.1007/s00424-009-0763-y. Epub 2009 Dec 5. Pflugers Arch. 2010. PMID: 19967386 Free PMC article. Review.
314 results